Web Analytics

Investor Profile

Eli Lilly and Company

Eli Lilly and Company United States - Indianapolis, Indiana
INVESTOR

1 Disclosed Funding Rounds $97,000,000
17 Participating Investments




For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs,

Invested In

Company Date Round Raised
  Volastra Therapeutics March, 08 ,2023 Series A $60,000,000
  Switch Therapeutics March, 15 ,2023 Series A $52,000,000
  Mediar Therapeutics March, 15 ,2023 Unknown $105,000,000
  Therini Bio, Inc. April, 27 ,2023 Series A $36,000,000
  DiogenX May, 11 ,2023 Series A $30,056,125
  Mozart Therapeutics, Inc June, 08 ,2023 Series A $25,000,000
  AltPep June, 26 ,2023 Series B $53,000,000
  Crossbow Therapeutics, Inc July, 12 ,2023 Series A $80,000,000
  Amber Bio August, 04 ,2023 Seed $26,000,000
  Mariana Oncology September, 08 ,2023 Series B $175,000,000
  Laverock Therapeutics September, 28 ,2023 Seed $16,470,000
  Sitryx September, 28 ,2023 Unknown $39,500,000
  OrsoBio November, 08 ,2023 Series A $60,000,000
  Vianautis November, 14 ,2023 Series A $25,000,000
  Alto Neuroscience November, 22 ,2023 Series C $45,000,000
  Capstan Therapeutics March, 21 ,2024 Series B $175,000,000
  Myricx Bio July, 09 ,2024 Series A $115,246,800